JV, E., GV, V., TR, S., TA, K., NV, K., D, K., . . . EV, K. (2020). Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia. BMC infectious diseases, 20(1), 543. https://doi.org/10.1186/s12879-020-05243-9
Chicago Style (17th ed.) CitationJV, Ershova, et al. "Impact of GeneXpert MTB/RIF® on Treatment Initiation and Outcomes of RIF-resistant and RIF-susceptible TB Patients in Vladimir TB Dispensary, Russia." BMC Infectious Diseases 20, no. 1 (2020): 543. https://doi.org/10.1186/s12879-020-05243-9.
MLA (9th ed.) CitationJV, Ershova, et al. "Impact of GeneXpert MTB/RIF® on Treatment Initiation and Outcomes of RIF-resistant and RIF-susceptible TB Patients in Vladimir TB Dispensary, Russia." BMC Infectious Diseases, vol. 20, no. 1, 2020, p. 543, https://doi.org/10.1186/s12879-020-05243-9.